{"version":"1.0","type":"link","title":"Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population.","author_name":"Weber M 외","author_url":"https://prs-insight.online/author/Weber%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98138","thumbnail_width":1200,"thumbnail_height":630}